Bona named director of Benign Hematology at Smilow Cancer Hospital

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Robert Bona was named professor of medicine (hematology) and inaugural director of the Benign Hematology Program at Smilow Cancer Hospital. He will also join as Medical Director of the Hemophilia Treatment Center for the Pediatric Hematology & Oncology Program at Smilow Cancer Hospital.

Bona will begin in his roles July 1.

Bona has been serving as a part-time member of the hematology department at Yale Cancer Center for the last three years.

Bona joins Yale from Quinnipiac University where he is a founding faculty member and professor of medical sciences at the Frank H. Netter MD School of Medicine. Bona has led several research studies, clinical trials, and care innovations to advance the treatment of blood diseases.

Table of Contents

YOU MAY BE INTERESTED IN

In 1971, the National Cancer Act set the United States on a path to confront one of its most formidable public health challenges. More than five decades later, the progress is undeniable. The latest 2026 report from the American Cancer Society shows continued declines in overall cancer mortality and improvements in survival for many major cancer types. Recent advances in early detection, prevention, and treatment are saving lives.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login